Navigation Links
Gene defect linked to dilated cardiomyopathy(DCM)

DCM is a condition which occurs when the heart becomes so enlarged that it is no longer able to pump blood efficiently. The condition affects 35 in every 100,000 people. Researchers in the United States have suggested in a recent study published in the journal Science that a defect in the gene phospholamban may trigger DCM. This gene plays a key role in regulating the flow of calcium through the heart, enabling it to beat effectively. The heart muscle// contracts and relaxes when calcium is released from a reservoir inside into the muscle cell and then pumped back quickly. Scientists have discovered that some people with inherited DCM show a subtle mutation in their phospholamban gene. Patients with DCM may suffer with tiredness, and shortness of breath whilst exercising or even whilst resting. They may have heart palpitations and notice their ankles becoming swollen.

Scientists used tests on mice to determine if a defect in this gene is enough to trigger DCM. They found that a mouse with a defect on the phospholamban gene also suffered severe damage to its heart. Further laboratory tests also showed that this defect disrupts the calcium pump in heart muscle cells. Scientists also found that people with this defect would suffer a chronic malfunction of calcium regulation in their heart muscle. Over time this would lead to heart failure.

Christine Seidman, who led the study, said that the discovery has led to the question of whether heart failure can be prevented if calcium cycle can be restored in this type of defect. The scientists involved in the study believe that this study may help them understand more about heart failure and also in the development of new drugs to treat the condition.


'"/>




Page: 1

Related medicine news :

1. CDC reveals relationship between prepregnant weight and heart defects in infants
2. Sex timing has no impact on risk of Birth defects
3. Infection in pregnancy can lead to congenital eye defects
4. Mutations in NOTCH1 cause an early developmental defect in the aortic valve
5. MicroRNA provides new insight into birth defects
6. Brain defect may play role in stammering
7. Folic acid enriched grain reduces birth defects
8. A call to epileptic mothers to help reduce birth defects
9. Guidant sold defective defibrillators with full knowledge
10. Fungal toxins infected corn the reason for congenital defects
11. Include folic acid in bread to reduce neural tube defects in new borns
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... , ... October 13, 2017 , ... ... and Agile Software Development, has been awarded a contract by the Center for ... Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in a ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... treating sleep apnea using cutting-edge Oventus O2Vent technology. As many as ... disorder characterized by frequent cessation in breathing. Oral appliances can offer significant relief ...
(Date:10/12/2017)... MD (PRWEB) , ... October 12, 2017 , ... The ... of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual ... – 8. , In honor of Morris F. Collen, a pioneer in the field ...
(Date:10/12/2017)... ... , ... HMP , a leader in healthcare events and education, today announced ... Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie ... competition recognizes editorial and design excellence across a range of sectors. This year’s program ...
(Date:10/12/2017)... ... ... Health Literacy Innovations (HLI), creator of the Health Literacy ... Patient Education Network (CPEN), an independent professional organization that shares best practices in ... , As CPEN’s strategic partner, HLI will help support CPEN members by sharing ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... --  Montrium , an industry leader in powerful ... Trial Master Files & Inspection Readiness Conference ( ... Services has selected eTMF Connect to ... a leading European contract research organization (CRO), will ... enable greater collaboration with sponsors, improve compliance and ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
(Date:9/22/2017)... 2017 AVACEN Medical (AVACEN) announced that its ... helping those with the widespread pain associated with fibromyalgia ... in Essex, England commented, "I ... experiencing no sleep at all, tremendous pain, with every ... recommend [the AVACEN 100] enough, how this has and ...
Breaking Medicine Technology: